RE: FDA due Q2 (I.e now)8 May 2026 20:25
I am in the same camp that next RNS could be FDA decision straight up.
As per 3 Dec 2025 RNS, just look at the rigorous process NEW YORK STATE have in place before granting approval. That in itself is a HUGE validation for FDA who requested extra details around clinical data collection etc.
Any folks not already in would be taking positions ahead of the big RNS next week.
On FDA approval RNS, this would open +50% up
We can also get NHS (UK) and Europe updates on Sales collaboration deals not just FDA (USA).